BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3628128)

  • 21. The incidence of anabolic steroid use among competitive bodybuilders.
    Tricker R; O'Neill MR; Cook D
    J Drug Educ; 1989; 19(4):313-25. PubMed ID: 2621538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.
    Curry LA; Wagman DF
    Percept Mot Skills; 1999 Feb; 88(1):224-33. PubMed ID: 10214647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anesthesia for athletes using performance-enhancing drugs.
    Joyce JA
    AANA J; 1991 Apr; 59(2):139-44. PubMed ID: 2035296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of doping agents, particularly anabolic steroids, in sports and society.
    Sjöqvist F; Garle M; Rane A
    Lancet; 2008 May; 371(9627):1872-82. PubMed ID: 18514731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem.
    Melnik B; Jansen T; Grabbe S
    J Dtsch Dermatol Ges; 2007 Feb; 5(2):110-7. PubMed ID: 17274777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anabolic steroids in athletics.
    Holden SC; Calvo RD; Sterling JC
    Tex Med; 1990 Mar; 86(3):32-6. PubMed ID: 2333633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anabolic steroids in the athlete.
    Strauss RH; Yesalis CE
    Annu Rev Med; 1991; 42():449-57. PubMed ID: 2035986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The adolescent athlete and ergogenic aids.
    Dyment PG
    J Adolesc Health Care; 1987 Jan; 8(1):68-73. PubMed ID: 3546227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical review 31: Anabolic-androgenic steroids and athletes: what are the issues?
    Rogol AD; Yesalis CE
    J Clin Endocrinol Metab; 1992 Mar; 74(3):465-9. PubMed ID: 1740476
    [No Abstract]   [Full Text] [Related]  

  • 30. [Estimated consumption of anabolic steroids among athletes in Denmark].
    Fauner M; Kisling A; Nielsen SL
    Nord Med; 1995; 110(1):23-5. PubMed ID: 7831105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions.
    Nieschlag E; Vorona E
    Eur J Endocrinol; 2015 Aug; 173(2):R47-58. PubMed ID: 25805894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dangers and risks of black market anabolic steroid abuse in sports --gas chromatography-mass spectrometry analyses].
    Ritsch M; Musshoff F
    Sportverletz Sportschaden; 2000 Mar; 14(1):1-11. PubMed ID: 10859788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anabolic androgenic steroids in amateur sports in the Netherlands].
    Woerdeman J; de Hon O; Levi M; de Ronde WP
    Ned Tijdschr Geneeskd; 2010; 154():A2004. PubMed ID: 20858322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters.
    Brower KJ; Eliopulos GA; Blow FC; Catlin DH; Beresford TP
    Am J Psychiatry; 1990 Apr; 147(4):510-2. PubMed ID: 2316741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The athletic polydrug abuse phenomenon. A case report.
    Hill JA; Suker JR; Sachs K; Brigham C
    Am J Sports Med; 1983; 11(4):269-71. PubMed ID: 6614301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anabolic-androgenic steroids: use and abuse in pediatric patients.
    Kerr JM; Congeni JA
    Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.
    Dickerman RD; McConathy WJ; Zachariah NY
    J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention.
    Mulcahey MK; Schiller JR; Hulstyn MJ
    Phys Sportsmed; 2010 Oct; 38(3):105-13. PubMed ID: 20959703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance-enhancing substances in adolescent athletes.
    Gomez JE
    Tex Med; 2002 Feb; 98(2):41-6. PubMed ID: 11862891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid Use.
    Dickerman RD; Schaller F; McConathy WJ
    Cardiology; 1998 Oct; 90(2):145-8. PubMed ID: 9778553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.